Sartorius Stedim Biotech’s BIOSTAT Cplus is a fermenter/bioreactor designed for the cultivation of microorganisms and cell cultures. The bioreactor is ideal for process development of vaccines, recombinant protein and monoclonal antibody production, biofuels, and secondary metabolites. Process strategy development can also be applied in batch, fed-batch, and continuous or perfusion operation, as well as scale-up and scale-down experiments. Culture vessels are available in operating volumes of 5, 10, 15, 20, and 30 liters.
A built-in sterilizable-in-place system is equipped with a DCU controller for upstream and downstream processes. The system allows up to four mass flow controllers and up to two scales or gravimetric feed controllers, and includes a pressure hold test to ensure control and safety. Each individual system can be adjusted for application-specific requirements, with automatic pressure control or integrated off-gas measurement options available.
Sartorius Stedim Biotechwww.sartorius.us
Tokyo University of Science Research Team Explores Improved Delivery of Antisense Oligonucleotides
April 18th 2025Using cholesterol-modified oligonucleotides, the research team aims to improve the delivery of antisense nucleotide-based therapies for treating neurodegenerative diseases and brain cancers.
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.
Teva and Samsung Bioepis Launch Biosimilar Eculizumab in US Market
April 17th 2025Eculizumab-aagh (EPYSQLI) is now available in the US to treat patients living with difficult-to-treat rare diseases such as paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and generalized myasthenia gravis.